RecruitingPhase 1NCT05986240

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Montefiore Medical Center
Principal Investigator
Aditi Shastri, MBBS
Montefiore Medical Center
Intervention
Danvatirsen(drug)
Enrollment
38 enrolled
Eligibility
18 years · All sexes
Timeline
20242030

Study locations (2)

Collaborators

M.D. Anderson Cancer Center · Flamingo Therapeutics NV

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05986240 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome

← Back to all trials